DIFFERENTIAL EXPRESSION OF PD-L1 ON HEMATOPOIETIC VERSUS TUMOR CELLS IN MEDULLOBLASTOMA

被引：0
|
作者：
Martin, Allison M. [1 ]
Nirschl, Christopher [1 ]
Polanczyk, Magda [1 ]
Bell, Robert [1 ]
Martinez, Daniel [2 ]
Sullivan, Lisa M. [2 ]
Santi, Mariarita [2 ]
Burger, Peter C. [1 ]
Taube, Janis M. [1 ]
Drake, Charles G. [1 ]
Pardoll, Drew M. [1 ]
Lim, Michael [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MB-073
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [1] PD-L1 expression of medulloblastoma
    Cakmak, P.
    Kolay, E.
    Poyraz, A.
    VIRCHOWS ARCHIV, 2018, 473 : S28 - S28
  • [2] Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells
    Xiaoqing Zhang
    Chen Cheng
    Jiyan Hou
    Xinyue Qi
    Xin Wang
    Ping Han
    Xuanming Yang
    Cellular & Molecular Immunology, 2019, 16 : 392 - 400
  • [3] The efficacy of PD-L1 blockade on PD-L1 negative medulloblastoma is dependent on timing and the tumor microenvironment
    Allen, Frederick
    Dorand, Rodney Dixon
    Rauhe, Peter
    Petrosiute, Agne
    Huang, Alex Y.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [4] Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells
    Zhang, Xiaoqing
    Cheng, Chen
    Hou, Jiyan
    Qi, Xinyue
    Wang, Xin
    Han, Ping
    Yang, Xuanming
    CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (04) : 392 - 400
  • [5] Does PD-L1 Positivity in Inflammatory Cells Correlate with PD-L1 Expression in Tumor Cells in Colorectal Adenocarcinoma?
    Broadwater, D. R.
    Williams, G.
    Messersmith, L.
    Brady, R.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S157 - S157
  • [6] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [7] Mechanisms regulating PD-L1 expression on tumor and immune cells
    Chen, Shuming
    Crabill, George A.
    Pritchard, Theresa S.
    McMiller, Tracee L.
    Wei, Ping
    Pardoll, Drew M.
    Pan, Fan
    Topalian, Suzanne L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [8] Differential expression of PD-L1 on circulating tumor cells among patients with advanced lung cancer
    Kim, Woong
    Koh, Yasuhiro
    Akamatsu, Hiroaki
    Yagi, Satomi
    Tanaka, Ayaka
    Kanai, Kuninobu
    Hayata, Atsushi
    Shibaki, Ryota
    Higuchi, Masayuki
    Kanbara, Hisashige
    Kikuchi, Takashi
    Akamatsu, Keiichiro
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    CANCER RESEARCH, 2016, 76
  • [9] Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)
    Kowanetz, Marcin
    Zou, Wei
    Gettinger, Scott N.
    Koeppen, Hartmut
    Kockx, Mark
    Schmid, Peter
    Kadel, Edward E., III
    Wistuba, Ignacio
    Chaft, Jamie
    Rizvi, Naiyer A.
    Spigel, David R.
    Spira, Alexander
    Hirsch, Fred R.
    Cohen, Victor
    Smith, Dustin
    Boyd, Zach
    Miley, Natasha
    Flynn, Susan
    Leveque, Vincent
    Shames, David S.
    Ballinger, Marcus
    Mocci, Simonetta
    Shankar, Geetha
    Funke, Roel
    Hampton, Garret
    Sandler, Alan
    Amler, Lukas
    Mellman, Ira
    Chen, Daniel S.
    Hegde, Priti S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (43) : E10119 - E10126
  • [10] PD-L1 Expression on Cytological Imprints and Circulating Tumor Cells versus Standardized Immunohistochemistry in NSCLC
    Abdo, M.
    Belloum, Y.
    Heigener, D.
    Welker, L.
    Schmidt, M.
    Heuer-Olewinski, N.
    Elmas, H.
    Perner, S.
    Wikman, H.
    Pantel, K.
    Reck, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S559 - S560
12345